Physician
Riverwalk Pediatric Clinic INC
Riverwalk Pediatric Clinic INC was paid $7.68M by Medicaid between Jan 2018 and Mar 2022, across 65 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoRIVERWALK PEDIATRIC CLINIC INC
BAKERSFIELD, CA 93311
BAKERSFIELD, CA 93311
33aNPI1417910886assigned 04/07/2006
33bProvider typePediatrics Physician
28Total paid$7.68M
24GClaims276,290
24DCodes billed65
24AFirst – last monthJan 2018 – Mar 2022
Compared with peers
Next to other Pediatrics Physician providers in California
Rank by total paid#27 of 1,490
Median peer was paid$15K
This provider vs. median512×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 57,057 | $1.50M | |
| 2019 | 66,464 | $1.82M | |
| 2020 | 65,415 | $1.85M | |
| 2021 | 75,237 | $2.16M | |
| 2022 | 12,117 | $350K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 80,769 | 72,192 | $2.89M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.7% | 11,337 | 11,289 | $516K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.6% | 9,260 | 9,239 | $505K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 5.8% | 8,692 | 8,545 | $447K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 5.3% | 6,639 | 6,626 | $410K |
| G9920 | Screening performed and negative | 5.3% | 12,039 | 12,025 | $405K |
| 90686 | 3.9% | 12,196 | 12,165 | $296K | |
| 99460 | 2.8% | 3,443 | 3,418 | $219K | |
| 92551 | 2.1% | 13,369 | 13,342 | $162K | |
| 99381 | 1.8% | 1,775 | 1,752 | $136K | |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.7% | 2,482 | 2,476 | $131K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.7% | 3,332 | 3,267 | $129K |
53 more codes
| 99238 | Hospital discharge day management, 30 minutes or less | 1.4% | 2,382 | $110K |
| 99188 | 1.4% | 5,408 | $108K | |
| 90670 | 1.4% | 8,230 | $106K | |
| 90700 | 1.1% | 4,009 | $85K | |
| 99173 | 1.0% | 17,083 | $80K | |
| 90744 | <1% | 4,436 | $71K | |
| 90698 | <1% | 6,149 | $68K | |
| 90651 | <1% | 3,641 | $66K | |
| 90680 | <1% | 5,126 | $61K | |
| 90633 | <1% | 4,270 | $60K | |
| 90734 | <1% | 2,437 | $54K | |
| 90707 | <1% | 4,045 | $46K | |
| 90716 | <1% | 4,088 | $46K | |
| 99383 | <1% | 651 | $46K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 5,162 | $33K |
| 92552 | <1% | 1,957 | $31K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 4,405 | $27K |
| 90620 | <1% | 1,766 | $25K | |
| 99462 | <1% | 743 | $24K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 495 | $24K |
| 85013 | <1% | 10,656 | $22K | |
| 83655 | <1% | 1,674 | $21K | |
| 90713 | <1% | 1,878 | $21K | |
| 99382 | <1% | 347 | $20K | |
| 90715 | <1% | 1,635 | $18K | |
| 90685 | <1% | 1,371 | $17K | |
| 0001A | <1% | 427 | $17K | |
| 90648 | <1% | 1,468 | $16K | |
| D1206 | Topical application of fluoride varnish | <1% | 713 | $16K |
| 0002A | <1% | 382 | $15K | |
| 0071A | <1% | 352 | $14K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 13 | $13K |
| 0072A | <1% | 297 | $12K | |
| 90619 | <1% | 415 | $11K | |
| 99384 | <1% | 114 | $9K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 88 | $7K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 337 | $5K |
| G9919 | Screening performed and positive and provision of recommendations | <1% | 131 | $4K |
| 90672 | <1% | 98 | $3K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 55 | $2K |
| 0004A | <1% | 48 | $2K | |
| 90660 | <1% | 53 | $2K | |
| 86580 | <1% | 441 | $1K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 297 | $1K |
| 81002 | <1% | 422 | $665.95 | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 31 | $390.00 |
| 90696 | <1% | 13 | $235.12 | |
| 99000 | <1% | 279 | $10.81 | |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 239 | $10.72 |
| 97803 | 0% | 26 | $0.00 | |
| 36416 | 0% | 36 | $0.00 | |
| G9008 | Coordinated care fee, physician coordinated care oversight services | 0% | 112 | $0.00 |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialAMIN, HASMUKH (PRESIDENT)